FDA staffing shortages and mounting supply pressures are reshaping clinical trials, requiring even closer coordination across regulatory, manufacturing, and operations.
Global shifts are rewriting the rules of clinical supply. Rising costs, regional regulations, and material scarcity mean planners must rethink strategies or risk costly disruptions.
How material traits, dosing approaches, and equipment design affect capsule‑filling accuracy and efficiency, giving teams insight to improve dose precision and support small‑scale manufacturing.
It is crucial to ensure that CGT supply chain risks are mitigated, as well as to have proactive strategies in place to address unforeseen challenges before they become an issue.
By offering guidance on optimizing ROI from extensive data collections and various endpoints in clinical studies, learn how IRT technology can enhance the data-driven approach for sponsors.
.png){kind=logo}
